Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team. Bani-Sadr F, et al. Among authors: lapidus n. Clin Infect Dis. 2008 Mar 1;46(5):768-74. doi: 10.1086/527565. Clin Infect Dis. 2008. PMID: 18248298
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
Bani-Sadr F, Goderel I, Lapidus N, Driss H, Simon A, Rosenthal E, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; ANRS HC02 - RIBAVIC Study Team. Bani-Sadr F, et al. Among authors: lapidus n. AIDS. 2008 Jul 11;22(11):1385-7. doi: 10.1097/QAD.0b013e328305bd8d. AIDS. 2008. PMID: 18580626 Free article. Clinical Trial. No abstract available.
Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.
Bani-Sadr F, Lapidus N, Rosenthal E, Gerard L, Foltzer A, Perronne C, Cacoub P, Pol S, Carrat F; ANRS HC02-Ribavic Study Team. Bani-Sadr F, et al. Among authors: lapidus n. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):429-30. doi: 10.1097/QAI.0b013e31819a2429. J Acquir Immune Defic Syndr. 2009. PMID: 19322037 Clinical Trial. No abstract available.
Planning for the next influenza H1N1 season: a modelling study.
Carrat F, Pelat C, Levy-Bruhl D, Bonmarin I, Lapidus N. Carrat F, et al. Among authors: lapidus n. BMC Infect Dis. 2010 Oct 21;10:301. doi: 10.1186/1471-2334-10-301. BMC Infect Dis. 2010. PMID: 20964814 Free PMC article.
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F. Lapidus N, et al. PLoS One. 2013 Apr 16;8(4):e60127. doi: 10.1371/journal.pone.0060127. Print 2013. PLoS One. 2013. PMID: 23613718 Free PMC article.
98 results